Mutations in exon 10 of RBM10 can significantly promote the proliferation and invasion of tumor cells, and the 5-year survival rate of patients with these mutations was significantly lower than that observed in healthy individuals (36.4 vs. 46.5% of RBM 10 wild type; χ2 = 5.466, P = 0.019) (25). Here, RBM10 is linked to neoplasm.